Primary Biliary Cholangitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed by a doctor with autoimmune hepatitis (a condition where the immune system attacks the liver)
- You have been diagnosed by a doctor with primary sclerosing cholangitis (a condition where the bile ducts in the liver become inflamed and scarred)
- You have been diagnosed by a doctor with autoimmune sclerosing cholangitis (a condition combining features of both autoimmune hepatitis and primary sclerosing cholangitis)
Who may not be able to join:
- You have previously had a liver transplant
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Amy E Taylor, MD, Children's Hospital Medical Center, Cincinnati
Phone: 513-636-4415
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Baseline disease characteristics in the population; Disease relapse and biochemical remission rates; Complications of disease; Side-effects of steroids; Pediatric Quality of Life Inventory (PedsQL 4.0) Generic Core Scales Short Form 15; Racial and ethnic disparities
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.